Laurie Heilmann

Biography

 Laurie Heilmann brings more than 25 years of executive leadership experience and an exceptional track record in business development optimization to her role at CrownBio. Versed in the creation and development of new business channels and marketing strategies within the life sciences industry, Heilmann has led initiatives in biotech, drug development, medical devices, and health care technologies. Her diverse therapeutic background, particularly in oncology and metabolism, is essential for proffering CrownBio's preclinical services and products worldwide for biotech and pharmaceutical companies. Before joining CrownBio, Heilmann held senior positions in prominent drug and device development companies and was an executive director at Strong-Bridge Consulting, where she created the firm's health care and life sciences practice. She also helped establish the for-profit division of the American College of Radiology in her role as VP of Global Sales and Business Development at Image Metrix, and she achieved 140% of goal sales in the company's first fiscal year. In previous roles, Heilmann: Led global sales and business development initiatives for enterprise-wide software solutions in numerous heath care segments, two of which resulted in successful IPOs. Restarted a global core ECG CRO, increased its sales tenfold, and successfully positioned the company for sale. Co-founded and grew a niche Oncology CRO from five partners to 250 employees in less than five years and successfully sold the company a year later. Created and executed market strategies that generated 89% incremental annual sales in three years, with 40% less-than-planned manpower. Heilmann's synthesis of business, clinical research, and technological acumen is ideal for assessing needs and assembling strategically sound, high-value solutions for CrownBio's clients. Her multifaceted experience from concept to commercialization, and knowledge of FDA and sponsor requirements in the US, Europe, India, and Asia, is vital to CrownBio's strategic global growth, as well as its expansion in the preclinical services market. She is an active member of numerous industry organizations, is a registered nurse, and holds a bachelor's degree in business. 

Research Interest

 Heilmann's synthesis of business, clinical research, and technological acumen is ideal for assessing needs and assembling strategically sound, high-value solutions for CrownBio's clients. Her multifaceted experience from concept to commercialization, and knowledge of FDA and sponsor requirements in the US, Europe, India, and Asia, is vital to CrownBio's strategic global growth, as well as its expansion in the preclinical services market. She is an active member of numerous industry organizations, is a registered nurse, and holds a bachelor's degree in business.